CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Effect of Pridopidine in Huntington Disease (HD) Patients and Healthy Volunteers (HVs) – A Simultaneous Sigma-1 Receptor PET/Multimodality MRI Study
DOI 10.1055/s-0040-1708414
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Barthel, PM Meyer, M Rullmann, G Becker, M Bronzel, D Marsteller, O Voges, F Zientek, B Sattler, M Patt, E Strauss, A Kluge, JM Savola, MF Gordon, M Geva, S Hesse, M Hayden, ID Grachev, O Sabri
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2020
Jahrgang / SeitenJg. 59
Kernaussage aus der Literatur
Abstract-Vorschau
Effect of Pridopidine in Huntington Disease (HD) Patients and Healthy Volunteers (HVs) – A Simultaneous Sigma-1 Receptor PET/Multimodality MRI Study
Zitieren
Zitierempfehlung
H Barthel, PM Meyer, M Rullmann, G Becker, M Bronzel, D Marsteller, O Voges, F Zientek, B Sattler, M Patt, E Strauss, A Kluge, JM Savola, MF Gordon, M Geva, S Hesse, M Hayden, ID Grachev, O Sabri (2020) Effect of Pridopidine in Huntington Disease (HD) Patients and Healthy Volunteers (HVs) – A Simultaneous Sigma-1 Receptor PET/Multimodality MRI Study. Nuklearmedizin - NuclearMedicine, 59 (02). https://doi.org/10.1055/s-0040-1708414
Mit CareLit weiterarbeiten